Sirtuin 1 promotes autophagy and proliferation of endometrial cancer cells by reducing acetylation level of LC3
- PMID: 33438275
- DOI: 10.1002/cbin.11549
Sirtuin 1 promotes autophagy and proliferation of endometrial cancer cells by reducing acetylation level of LC3
Abstract
Endometrial cancer (EC) constitutes a common female genital tract tumor with a rising incidence rate. Sirtuin 1 (SIRT1) is a member of histone deacetylase, which extensively participates in the progression of aging, cell death, and tumorigenesis. This study explored the effect of SIRT1-mediated LC3 acetylation on autophagy and proliferation of EC cells. SIRT1 expression in EC tissues and adjacent tissues, EC cell lines and normal human epithelial cells was detected. SIRT1 expression was elevated in EC cell lines and tissues. Knockdown of SIRT1 inhibited proliferation, migration, and invasion of EC cells. Then, EC cells were starved in serum-free medium, and levels of autophagy-related proteins were detected. Starvation induced autophagy of EC cells. The starvation-treated EC cells showed an increased SIRT1 expression, a decreased LC3 acetylation level and an increased autophagy level. The proliferation and autophagy of EC cells under different treatments were evaluated. In EC cells transfected with overexpressing SIRT1, LC3 acetylation was inhibited and cell proliferation was promoted. Moreover, overexpressing SIRT1 facilitated growth and autophagy of transplanted tumors in nude mice. In conclusion, SIRT1 promoted autophagy and proliferation of EC cells by reducing acetylation level of LC3.
Keywords: LC3; Sirtuin 1; acetylation; autophagy; endometrial cancer; proliferation.
© 2021 International Federation for Cell Biology.
Similar articles
-
SIRT1-mediated deacetylation of FOXO3 enhances mitophagy and drives hormone resistance in endometrial cancer.Mol Med. 2024 Sep 12;30(1):147. doi: 10.1186/s10020-024-00915-7. Mol Med. 2024. PMID: 39266959 Free PMC article.
-
Inhibition of ACSS2 triggers glycolysis inhibition and nuclear translocation to activate SIRT1/ATG5/ATG2B deacetylation axis, promoting autophagy and reducing malignancy and chemoresistance in ovarian cancer.Metabolism. 2025 Jan;162:156041. doi: 10.1016/j.metabol.2024.156041. Epub 2024 Oct 2. Metabolism. 2025. PMID: 39362518
-
Sirtuin 1 promotes the growth and cisplatin resistance of endometrial carcinoma cells: a novel therapeutic target.Lab Invest. 2015 Dec;95(12):1363-73. doi: 10.1038/labinvest.2015.119. Epub 2015 Sep 14. Lab Invest. 2015. PMID: 26367491
-
SIRT1 and gynecological malignancies (Review).Oncol Rep. 2021 Apr;45(4):43. doi: 10.3892/or.2021.7994. Epub 2021 Mar 2. Oncol Rep. 2021. PMID: 33649834 Free PMC article. Review.
-
SIRT1 - a new mammalian substrate of nuclear autophagy.Autophagy. 2021 Feb;17(2):593-595. doi: 10.1080/15548627.2020.1860541. Epub 2020 Dec 20. Autophagy. 2021. PMID: 33292048 Free PMC article. Review.
Cited by
-
Non-Genomic Hallmarks of Aging-The Review.Int J Mol Sci. 2023 Oct 23;24(20):15468. doi: 10.3390/ijms242015468. Int J Mol Sci. 2023. PMID: 37895144 Free PMC article. Review.
-
Chromium Affects Mitochondrial Function, Leading to Apoptosis and Autophagy in Turtle Primary Hepatocytes.Animals (Basel). 2024 Aug 19;14(16):2403. doi: 10.3390/ani14162403. Animals (Basel). 2024. PMID: 39199937 Free PMC article.
-
Impact of sirtuin‑1 expression on progression‑free survival in non‑endometrioid endometrial cancer: A retrospective cohort study.Oncol Lett. 2025 Mar 20;29(5):239. doi: 10.3892/ol.2025.14985. eCollection 2025 May. Oncol Lett. 2025. PMID: 40486084 Free PMC article.
-
[Puerarin alleviates lipopolysaccharide-induced acute kidney injury in mice by modulating the SIRT1/NF-κB pathway].Nan Fang Yi Ke Da Xue Xue Bao. 2023 Jul 20;43(7):1248-1253. doi: 10.12122/j.issn.1673-4254.2023.07.22. Nan Fang Yi Ke Da Xue Xue Bao. 2023. PMID: 37488808 Free PMC article. Chinese.
-
Uterine-specific SIRT1 deficiency confers premature uterine aging and impairs invasion and spacing of blastocyst, and stromal cell decidualization, in mice.Mol Hum Reprod. 2022 Jun 30;28(7):gaac016. doi: 10.1093/molehr/gaac016. Mol Hum Reprod. 2022. PMID: 35536234 Free PMC article.
References
REFERENCES
-
- Amaravadi, R., Kimmelman, A. C., & White, E. (2016). Recent insights into the function of autophagy in cancer. Genes and Development, 30, 1913-1930.
-
- Asaka, R., Miyamoto, T., Yamada, Y., Ando, H., Mvunta, D. H., Kobara, H., & Shiozawa, T. (2015). Sirtuin 1 promotes the growth and cisplatin resistance of endometrial carcinoma cells: a novel therapeutic target. Laboratory Investigation, 95, 1363-1373.
-
- Bartosch, C., Monteiro-Reis, S., Almeida-Rios, D., Vieira, R., Castro, A., Moutinho, M., Rodrigues, M., Graca, I., Lopes, J. M., & Jeronimo, C. (2016). Assessing sirtuin expression in endometrial carcinoma and non-neoplastic endometrium. Oncotarget, 7, 1144-1154.
-
- Beyer, S., Chen, F., Meister, S., Czogalla, B., Kolben, T. M., Hester, A., Burges, A., Trillsch, F., Schmockel, E., Mayr, D., Mayerhofer, A., Mahner, S., Jeschke, U., & Kolben, T. (2020). Sirtuin1 expression and survival in endometrial and clear-cell uterine cancer. Histochemistry and Cell Biology, 154, 189-195.
-
- Choupani, J., Mansoori Derakhshan, S., Bayat, S., Alivand, M. R., & Shekari Khaniani, M. (2018). Narrower insight to SIRT1 role in cancer: A potential therapeutic target to control epithelial-mesenchymal transition in cancer cells. Journal of Cellular Physiology, 233, 4443-4457.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources